Evrysdi 50242-0202-01
Generic: Risdiplam
- Manufacturer
- Genentech, Inc.
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- February 11, 2025
- Listing Expires
- December 31, 2027
- Application
- NDA219285
Need to source Evrysdi? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Risdiplam | 5 mg/1 |
Drug Class
Survival of Motor Neuron 2 Splicing Modifier [EPC]Increased Protein Synthesis [PE]Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]
Selected Package
50242-0202-01Selected1 BOTTLE, PLASTIC in 1 CARTON (50242-202-01) / 30 TABLET in 1 BOTTLE, PLASTIC